Holen Sie sich die Stockscreener-App
351.90
2.43%
-8.77
Handel nachbörslich:
354.90
3.00
+0.85%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ELV?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$360.67
Offen:
$360.41
24-Stunden-Volumen:
1.20M
Relative Volume:
0.69
Marktkapitalisierung:
$78.21B
Einnahmen:
$194.82B
Nettoeinkommen (Verlust:
$5.53B
KGV:
14.39
EPS:
24.4514
Netto-Cashflow:
$3.77B
1W Leistung:
+6.70%
1M Leistung:
+8.00%
6M Leistung:
-6.54%
1J Leistung:
-5.73%
1-Tages-Spanne:
$348.59
$361.55
1-Wochen-Bereich:
$325.29
$363.50
52-Wochen-Spanne:
$273.71
$458.73
Elevance Health Inc Stock (ELV) Company Profile
Firmenname
Elevance Health Inc
Sektor
Branche
Telefon
(800) 331-1476
Adresse
220 VIRGINIA AVENUE, INDIANAPOLIS
Vergleichen Sie ELV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELV
Elevance Health Inc
|
351.90 | 80.15B | 194.82B | 5.53B | 3.77B | 24.45 |
|
UNH
Unitedhealth Group Inc
|
334.20 | 308.98B | 435.16B | 18.37B | 17.37B | 19.16 |
|
CVS
Cvs Health Corp
|
78.29 | 101.16B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
CI
Cigna Group
|
276.11 | 74.03B | 268.22B | 6.55B | 7.44B | 22.67 |
|
HUM
Humana Inc
|
258.16 | 33.04B | 123.11B | 1.58B | 2.44B | 13.03 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-14 | Eingeleitet | Goldman | Neutral |
| 2025-07-21 | Herabstufung | Argus | Buy → Hold |
| 2025-07-18 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-03-17 | Hochstufung | Argus | Hold → Buy |
| 2025-01-22 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-10-18 | Herabstufung | Argus | Buy → Hold |
| 2024-07-18 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-06-24 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2023-07-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2023-04-27 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-03-28 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-09-09 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-08-22 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
Alle ansehen
Elevance Health Inc Aktie (ELV) Neueste Nachrichten
Insiders At Elevance Health Sold US$3.5m In Stock, Alluding To Potential Weakness - Yahoo Finance
Elevance Health (ELV) Stock: December 2025 Outlook After Q3 Earnings Beat, Legal Headwinds and New Analyst Targets - ts2.tech
Anthem Blue Cross and Blue Shield Foundation Awards More Than $1M to Support Maternal Health Programs Across Virginia - Business Wire
Anthem Blue Cross and Blue Shield Foundation Awards $200,000 to Support Maternal Health Programs in New York - Business Wire
Liontrust Investment Partners LLP Reduces Stock Position in Elevance Health, Inc. $ELV - MarketBeat
National Bank of Canada FI Trims Stock Holdings in Elevance Health, Inc. $ELV - MarketBeat
MASTERINVEST Kapitalanlage GmbH Invests $1.99 Million in Elevance Health, Inc. $ELV - MarketBeat
Hyperion Capital Advisors LP Purchases 9,000 Shares of Elevance Health, Inc. $ELV - MarketBeat
Geneos Wealth Management Inc. Purchases 7,098 Shares of Elevance Health, Inc. $ELV - MarketBeat
Anthem Blue Cross Provides $1.5 Million for Wildfire Recovery in Los Angeles County, With Altadena and Pasadena Support – Pasadena Now - Pasadena Now
GCM Grosvenor Holdings LLC Sells 3,030 Shares of Elevance Health, Inc. $ELV - MarketBeat
Eminence Capital LP Has $93.80 Million Stake in Elevance Health, Inc. $ELV - MarketBeat
Brevan Howard Capital Management LP Makes New $13.80 Million Investment in Elevance Health, Inc. $ELV - MarketBeat
Elevance Health, Inc. $ELV is Brave Warrior Advisors LLC's 3rd Largest Position - MarketBeat
BI Asset Management Fondsmaeglerselskab A S Grows Stock Holdings in Elevance Health, Inc. $ELV - MarketBeat
Bellevue Group AG Raises Stock Position in Elevance Health, Inc. $ELV - MarketBeat
Ameriprise Financial Inc. Has $730.01 Million Stock Position in Elevance Health, Inc. $ELV - MarketBeat
Elevance Health (NYSE:ELV) Stock Rating Lowered by Wall Street Zen - MarketBeat
Elevance Health Stock (NYSE: ELV) News Today: Credit Ratings, ACA Subsidy Vote, and Analyst Forecasts on Dec. 12, 2025 - ts2.tech
Elevance Health (ELV) advances data-driven, person-centered health plan model - Stock Titan
AM Best Takes Various Credit Rating Actions on Elevance Health, Inc. and Most of Its Subsidiaries - The AI Journal
Elevance Health (ELV) Stock News Today: ACA Subsidy Deadline Looms, Fitch Affirms A- Rating, and Analysts See Modest Upside (Dec. 12, 2025) - ts2.tech
Elevance Health, Inc. $ELV Shares Acquired by Parkwood LLC - MarketBeat
Ilex Capital Partners UK LLP Cuts Stock Holdings in Elevance Health, Inc. $ELV - MarketBeat
Elevance Health, Inc. $ELV Shares Sold by Alliancebernstein L.P. - MarketBeat
Elevance Health Inc. stock outperforms competitors on strong trading day - MSN
Elevance Health Adds Former Pfizer GC To Its Board - Law360
How Investors May Respond To Elevance Health (ELV) Expanding AI Assistant Access And Adding Schulman To Board - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Encourages Elevance Health, Inc. (ELV) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Elevance Health (NYSE:ELV) Given New $340.00 Price Target at Robert W. Baird - MarketBeat
Baird Adjusts Price Target on Elevance Health to $340 From $297, Maintains Neutral Rating - marketscreener.com
The Manufacturers Life Insurance Company Buys 487,579 Shares of Elevance Health, Inc. $ELV - MarketBeat
Bank of Nova Scotia Has $11.54 Million Position in Elevance Health, Inc. $ELV - MarketBeat
Elevance Health (ELV) Appoints Amy W. Schulman as Independent Di - GuruFocus
Elevance Health appoints healthcare executive Amy Schulman to board - Investing.com
Elevance Health appoints healthcare executive Amy Schulman to board By Investing.com - Investing.com UK
Elevance Health Board Welcomes Amy Schulman as New Director, Reflecting Ongoing Commitment to Governance Excellence - Markets Financial Content
Wall Street Outlook For Elevance Health, Inc. (ELV) Supported By Prior TD Cowen Upgrade - Finviz
Behind the Curtain: How UnitedHealth is Rewriting its Own Rules - TradingView
State Street Corp Trims Stake in Elevance Health, Inc. $ELV - MarketBeat
Daiwa Securities Group Inc. Acquires 6,396 Shares of Elevance Health, Inc. $ELV - MarketBeat
Archon Partners LLC Trims Holdings in Elevance Health, Inc. $ELV - MarketBeat
Axa S.A. Increases Stock Holdings in Elevance Health, Inc. $ELV - MarketBeat
Elevance Health, Inc. (NYSE:ELV) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Elevance Health Foundation Expands Support for Creating Healthier Communities' Better Births Initiative - The Malaysian Reserve
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elevance Health, Inc. (ELV) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Elevance Health, Inc. $ELV Shares Acquired by Investment Management Corp of Ontario - MarketBeat
Natixis Sells 55,088 Shares of Elevance Health, Inc. $ELV - MarketBeat
Cerity Partners LLC Increases Stock Position in Elevance Health, Inc. $ELV - MarketBeat
Can UNH's AI-Powered Virtual Assistance Enhance Member Experience? - The Globe and Mail
SVB Wealth LLC Has $8.12 Million Position in Elevance Health, Inc. $ELV - MarketBeat
Finanzdaten der Elevance Health Inc-Aktie (ELV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):